# Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

> **NCT00048607** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 600 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** aprepitant
- **DRUG:** Comparator: paroxetine HCL
- **DRUG:** Comparator: Placebo (Unspecified)

## Key facts

- **NCT ID:** NCT00048607
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07-30
- **Primary completion:** 2003-12-31
- **Final completion:** 2003-12-31
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2017-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048607, "Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00048607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*